BPC-157/TB-500/GHK-Cu/KPV BlendAlso known as: BTG-K Blend, Body Protection Compound (BPC-157), Thymosin Beta-4 (TB-500), Copper Peptide (GHK-Cu), Lysine-Proline-Valine (KPV)

Mechanism of Action

The blend combines synergistic peptides targeting multiple regenerative pathways: BPC-157 promotes tissue healing via vascular endothelial growth factor (VEGF) induction enhancing angiogenesis and cytoprotection; TB-500 facilitates cell migration and angiogenesis through actin regulation; GHK-Cu stimulates collagen synthesis and serves as an antioxidant promoting skin remodeling; KPV exerts anti-inflammatory effects by modulating cytokine activity and suppressing proinflammatory responses. Together, they accelerate repair processes, reduce inflammation, and enhance tissue regeneration at cellular and molecular levels.

Reported Research Benefits

Preclinical research into muscle recovery, tendon and ligament repair, wound healing, anti-aging skin therapies, neuroprotective strategies, angiogenesis promotion, and immunomodulation. Widely used in laboratory studies related to regenerative medicine, dermatology, and immune responses.

Dosing Protocol & Reconstitution

Delivered as lyophilized powder, typically reconstituted with bacteriostatic water for subcutaneous injection. Research doses in preclinical models vary, commonly around 10 mg components per vial in the blend. Administration often performed daily in controlled laboratory protocols using insulin syringes. Exact dosing depends on experimental design.

Research Notes

Demonstrates accelerated wound closure, enhanced collagen deposition, improved muscle and nerve regeneration in animal models. Non-addictive and well-tolerated in experimental settings. Stability limited post-reconstitution (60 days refrigerated). COA confirms >99% purity indicating suitability for precise biomedical studies.

Research Summary

An expanded healing blend adding KPV (Lys-Pro-Val), a potent anti-inflammatory tripeptide derived from α-MSH, to the BPC-157/TB-500/GHK-Cu stack. KPV directly inhibits NF-κB signaling in intestinal epithelial cells and immune cells, making this combination particularly targeted at gut inflammation and systemic recovery.

Side Effects & Safety

Adds KPV's generally favorable safety profile to the existing blend. No documented serious adverse events in animal models for the combination.

Stability & Storage

Refer to research notes

Molecular Data

Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular Formula: C62H98N16O22
Molecular Weight: 1419.5 g/mol
CAS Number: 137525-51-0
IUPAC Name: N-(1-Oxo-3-propyl)-L-prolyl-L-prolyl-L-prolyl-L-glycyl-L-lysyl-L-prolyl-L-alanyl-L-aspartyl-L-aspartyl-L-alanyl-L-glycyl-L-leucyl-L-valylamide

Primary literature: https://pubmed.ncbi.nlm.nih.gov/?term=BPC-157+KPV+anti-inflammatory+peptide